Chih Hui Lin
Chief Executive Officer chez SYNMOSA BIOPHARMA CORPORATION
Profil
Chih Hui Lin is currently the Chairman, President & General Manager at Synmosa Biopharma Corp.
He is also the Chairman at Yu Chiao Co. Ltd., InnoPharmax, Inc., U-Liang Pharmaceutical Co. Ltd., and Intech Biopharm Ltd.
Mr. Lin completed his undergraduate degree at Taipei Medical University.
Postes actifs de Chih Hui Lin
| Sociétés | Poste | Début |
|---|---|---|
| SYNMOSA BIOPHARMA CORPORATION | Chief Executive Officer | 25/02/2011 |
| INNOPHARMAX INC. | Chairman | 21/03/2008 |
| INTECH BIOPHARM CORPORATION | Chairman | 28/10/2010 |
| Yu Chiao Co. Ltd. | Chairman | - |
U-Liang Pharmaceutical Co. Ltd.
 U-Liang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Synmosa Biopharma Corp., U-Liang Pharmaceutical Co. Ltd. is a Taiwanese company that manufactures and distributes pharmaceutical products. The private company is based in Taoyuan, Taiwan. U-Liang Pharmaceutical Co. was acquired by Synmosa Biopharma Corp. on March 07, 2013 for $2.50 million. | Chairman | - |
Formation de Chih Hui Lin
| Taipei Medical University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SYNMOSA BIOPHARMA CORPORATION | Health Technology |
| INNOPHARMAX INC. | Health Technology |
| INTECH BIOPHARM CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Yu Chiao Co. Ltd. | |
U-Liang Pharmaceutical Co. Ltd.
U-Liang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Synmosa Biopharma Corp., U-Liang Pharmaceutical Co. Ltd. is a Taiwanese company that manufactures and distributes pharmaceutical products. The private company is based in Taoyuan, Taiwan. U-Liang Pharmaceutical Co. was acquired by Synmosa Biopharma Corp. on March 07, 2013 for $2.50 million. | Health Technology |
